Total Payments
$5,452
2024 Payments
$928.11
Companies
17
Transactions
65
Medicare Patients
2,526
Medicare Billing
$635,798
Payment Breakdown by Category
Other$3,905 (71.6%)
Food & Beverage$1,547 (28.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,905 | 1 | 71.6% |
| Food and Beverage | $1,547 | 64 | 28.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| FUJIFILM Medical Systems USA, Inc. | $3,905 | 1 | $0 (2018) |
| ABBVIE INC. | $225.86 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $177.59 | 9 | $0 (2024) |
| Covidien LP | $172.85 | 2 | $0 (2019) |
| Olympus America Inc. | $143.12 | 5 | $0 (2024) |
| Boston Scientific Corporation | $136.89 | 2 | $0 (2019) |
| Wilson Cook Medical Incorporated | $122.38 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $106.87 | 5 | $0 (2024) |
| PENTAX of America, Inc. | $92.99 | 3 | $0 (2024) |
| Madrigal Pharmaceuticals | $90.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $928.11 | 49 | ABBVIE INC. ($205.37) |
| 2023 | $187.19 | 9 | Olympus America Inc. ($82.40) |
| 2019 | $185.00 | 3 | Covidien LP ($172.85) |
| 2018 | $3,905 | 1 | FUJIFILM Medical Systems USA, Inc. ($3,905) |
| 2017 | $247.12 | 3 | BOSTON SCIENTIFIC CORPORATION ($124.74) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: VIROLOGY | ||||||
| 11/06/2024 | Olympus America Inc. | Single Use Aspiration Needle NA-U200H (Device) | Food and Beverage | In-kind items and services | $39.81 | General |
| Category: Endotherapy | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 09/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 657 | 6,277 | $982,800 | $185,226 |
| 2022 | 21 | 580 | 5,971 | $952,408 | $174,186 |
| 2021 | 21 | 657 | 8,501 | $988,652 | $211,286 |
| 2020 | 18 | 632 | 701 | $657,990 | $65,100 |
Total Patients
2,526
Total Services
21,450
Medicare Billing
$635,798
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 13 | 5,100 | $178,500 | $87,454 | 49.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 155 | 158 | $284,400 | $31,726 | 11.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 359 | $35,900 | $13,095 | 36.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 211 | $31,650 | $10,183 | 32.2% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 18 | 19 | $45,600 | $6,441 | 14.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 81 | $109,350 | $5,283 | 4.8% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 32 | 32 | $32,000 | $4,711 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $25,200 | $4,233 | 16.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $84,000 | $3,635 | 4.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $36,300 | $2,540 | 7.0% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 17 | 18 | $36,000 | $2,540 | 7.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $12,000 | $2,341 | 19.5% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2023 | 13 | 13 | $14,300 | $2,305 | 16.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $19,500 | $2,203 | 11.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 18 | 20 | $8,000 | $1,970 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 25 | $7,500 | $1,477 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $4,200 | $903.60 | 21.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 11 | $8,800 | $902.95 | 10.3% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 34 | 38 | $5,700 | $682.86 | 12.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 14 | 26 | $3,900 | $601.81 | 15.4% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 14 | 4,500 | $155,700 | $77,553 | 49.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 163 | 167 | $299,788 | $32,662 | 10.9% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 11 | 790 | $110,600 | $22,275 | 20.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 58 | 58 | $78,300 | $4,579 | 5.8% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 12 | 12 | $28,800 | $4,353 | 15.1% |
About Dr. Charles Shrode, MD
Dr. Charles Shrode, MD is a Gastroenterology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295930956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Shrode, MD has received a total of $5,452 in payments from pharmaceutical and medical device companies, with $928.11 received in 2024. These payments were reported across 65 transactions from 17 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($3,905).
As a Medicare-enrolled provider, Shrode has provided services to 2,526 Medicare beneficiaries, totaling 21,450 services with total Medicare billing of $635,798. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Asheville, NC
- Active Since 06/20/2007
- Last Updated 10/23/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1295930956
Products in Payments
- ESD - Core Endoscopy (Device) $3,905
- Beacon (Device) $172.85
- SPYGLASS (Device) $124.74
- XIFAXAN (Drug) $117.53
- RINVOQ (Biological) $111.38
- DUPIXENT (Biological) $108.23
- ENTYVIO (Biological) $106.87
- Cook Medical Hemostasis (Device) $102.66
- INSPIRA (Device) $92.99
- RESMETIROM (Drug) $90.48
- SKYRIZI (Biological) $55.50
- Endocuff Vision (Device) $52.01
- TREMFYA (Drug) $49.89
- CREON (Drug) $42.21
- Linzess (Drug) $42.07
- TRULANCE (Drug) $41.58
- Single Use Aspiration Needle NA-U200H (Device) $39.81
- VISIGLIDE (Device) $30.39
- ZEPOSIA (Drug) $29.11
- EndoClot PHS (Device) $20.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Asheville
Adam Zivony, M.d, M.D
Gastroenterology — Payments: $179,865
Gastroenterology $179,865
Dr. Brian Garvin, Md, MD
Gastroenterology — Payments: $130,620
Gastroenterology $130,620
Jessica Fisher, M.d, M.D
Gastroenterology — Payments: $5,868
Gastroenterology $5,868
Dr. William Harlan, M.d, M.D
Gastroenterology — Payments: $5,312
Gastroenterology $5,312
Dr. Michael Heacock, M.d, M.D
Gastroenterology — Payments: $4,276
Gastroenterology $4,276
Dr. David May, M.d, M.D
Gastroenterology — Payments: $3,411
Gastroenterology $3,411